Ohio State appoints new leader of translational research, receives $37.9M NIH grant

We are delighted to announce the appointment of Julie Johnson, PharmD, as director of the Center for Clinical and Translational Science (CCTS), associate dean for Clinical and Translational Research in The Ohio State University College of Medicine and associate vice president of Research for The Ohio State University. She will also hold the Dr. Samuel T. and Lois Felts Mercer Professorship of Medicine and Pharmacology.

As director of the CCTS, Johnson is the principal investigator of a seven-year $37.9 million Clinical and Translation Science Award from the National Institutes of Health, which funds the center’s work to turn scientific discoveries into clinical therapies that improve human health for all. The grant supports collaborative research by Ohio State, Ohio State Wexner Medical Center and Nationwide Children's Hospital. This is the CCTS’ fourth cycle of NIH funding since 2008. 

With a health equity lens, this new grant will focus on the development of innovative methods and approaches to address roadblocks in clinical and translational research, support workforce development, increase collaboration across academic and scientific disciplines and expand access to research technologies.

Read more about Dr. Johnson and how the grant supports the work of the CCTS here.